# Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

> clinical trial · VERIFIED · 2026-07-21

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Anatomic Stage IV Breast Cancer AJCC v8

- Company: National Cancer Institute (NCI)
- Sector: Anatomic Stage IV Breast Cancer AJCC v8
- Primary source: https://clinicaltrials.gov/study/NCT03606967

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.